Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. The FDA cleared the company’s Control-IQ AID technology for use in pregnancy complicated by type 1 diabetes mellitus. Control-IQ+ powers both of Tandem’s available t:slim X2 and Mobi AID systems. San Diego-based Tandem says t:slim X2 […]
Tandem Diabetes Care
Tandem Diabetes Care reports positive findings for Control-IQ in low-bolusing youths
Tandem Diabetes Care (Nasdaq:TNDM) has shared new findings supporting the use of its Control-IQ technology in type 1 diabetes. San Diego-based Tandem’s study aimed to assess the differences in time in range (TIR) between automated insulin delivery (AID) systems in youth with low bolus frequency. It compared Tandem Control-IQ technology with an undisclosed disposable patch-based […]
Tandem Diabetes care launches Mobi pump on Android phones
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its Mobi automated insulin delivery system available with Android devices. San Diego-based Tandem said Mobi, the world’s smallest, durable automated insulin delivery system, can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. In November, Tandem announced that it received […]
Tandem Diabetes Care prices upsized $265M offering
Tandem Diabetes Care (Nasdaq:TNDM) today announced the pricing of a $265 million offering of convertible senior notes. San Diego-based Tandem earlier this week announced its intent to offer $200 million in notes, due 2032, in a private placement. It now says it upsized that offering by $65 million. The company also granted initial purchasers an […]
Tandem Diabetes Care announces $200M notes offering
This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here. Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]
Tandem stock rises on Q4 beats, new pay-as-you-go model
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 11.5% to $20.65 apiece after the market closed today. The San Diego-based automated insulin delivery technology developer reported losses of 589 million. That equals 1¢ per share on sales of $290.4 […]
The top diabetes tech stories of 2025
As the year comes to a close, it’s time to look back at the numerous innovations across the diabetes technology industry in 2025. Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter […]
Clinical Ink, Tandem Diabetes Care partner on automated insulin delivery data
Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care (Nasdaq:TNDM) to integrate automated insulin delivery (AID) data. The collaboration enables the integration of Tandem’s t:slim X2 and Mobi AID systems with Clinical Ink’s GlucoseReady platform. This would provide an automated method for capturing AID system data in clinical trials. In the partnership, […]
Tandem launches t:slim mobile app in Canada
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim mobile application for Android and iOS users in Canada. San Diego-based Tandem’s t:slim mobile app connects to the company’s t:slim X2 automated insulin delivery system. It enables users to deliver a bolus from their compatible smartphone. They can also wirelessly upload pump data to […]
What the launch of Mobi for Android means for Tandem, people with diabetes
This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world’s smallest, durable automated insulin delivery system — to […]
